EndoFertil: Infertility and Endometriosis Cohort

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Unknown status
CT.gov ID
NCT01833013
Collaborator
(none)
200
1
1
66
3

Study Details

Study Description

Brief Summary

Nowadays, one in six couples consults for fertility problems. If the standard examination and tests do not reveal any cause of infertility, the woman may undergo a laparoscopic exploration which reveals endometriosis in more than 50% of cases.

Endometriosis is an inflammatory disease defined as the presence of endometrial tissue out of the uterine cavity. It is frequent (1 in 10 women) and associated with a high economic burden (22 billion dollars in 2002 in the USA) and important decrease in quality of life. Physiopathological mechanisms and risk factors for endometriosis are not well identified.

A woman with endometriosis is 20 times more at risk of infertility. Fecundity rate of a 25-year-old couple is about 15 to 20% in the general population and only 2 to 10% in case of endometriosis.

There are many manifestations of this disease (infertility, pelvic pain) and the anatomo-clinical correlation is not good. The presently used international classification (American Fertility Society revised in 1985, AFSr) does not predict the chance of pregnancy. New scores such as the Endometriosis Fertility Index (EFI) have been proposed to do so, but need to be validated. Treatment for endometriosis-related infertility is not consensual.

A prospective cohort study would give access to clinical data of patients followed in our center, so as to identify clinical factors predicting pregnancy and to help treatment decision for women with endometriosis suffering from infertility.

Condition or Disease Intervention/Treatment Phase
  • Other: live birth date and quality of life assessment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Official Title:
Infertility and Endometriosis : a Prospective Cohort Study
Study Start Date :
Apr 1, 2013
Anticipated Primary Completion Date :
Apr 1, 2018
Anticipated Study Completion Date :
Oct 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: endometriosis cohort

females suffer from endometriosis

Other: live birth date and quality of life assessment

Outcome Measures

Primary Outcome Measures

  1. live birth date [3 years]

    Assessment of the number of live birth in the 3 years following the laparoscopic exploration making the diagnosis of endometriosis

Secondary Outcome Measures

  1. Quality of life [3 years]

    Assessment of the quality of life relating to infertility and endometriosis in the 3 years following laparoscopic exploration making the diagnosis of endometriosis.

  2. pain symptoms [3 years]

    Assessment of the pain symptoms relating to infertility and endometriosis in the 3 years following laparoscopic exploration making the diagnosis of endometriosis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 41 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Woman from 18 to 41 years old.

  • Dealing with infertility,

  • With a normal pelvic echography and hysterosalpingography, a normal hormonal status and a partner with a normal sperm.

  • For whom a laparoscopic exploration finds endometriosis.

  • Consenting to participate to the study.

Exclusion criteria:
  • Any contraindication for general anesthesia or for laparoscopy.

  • Any contraindication for pregnancy.

  • Follow-up is impossible.

  • Consent is impossible.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Montpellier Montpellier Herault France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Principal Investigator: Herve Dechaud, MD,PhD, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT01833013
Other Study ID Numbers:
  • 9113
First Posted:
Apr 16, 2013
Last Update Posted:
Jan 9, 2015
Last Verified:
Apr 1, 2013
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 9, 2015